Correction: HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C (PLoS One (2013) 8:12 (e82028) DOI: 10.1371/journal.pone.0082028);HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Bhasin, Bhavna ^a   Lau, Bryan ^a,b   Atta, Mohamed G ^a   Fine, Derek M ^a   Estrella, Michelle M ^a   Schwartz, George J ^c   Lucas, Gregory M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CREATININE; CYSTATIN C; HLA DR ANTIGEN; TENOFOVIR; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; T LYMPHOCYTE ACTIVATION; VIREMIA; BLOOD; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

CD8-POSITIVE T-LYMPHOCYTES; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; VIREMIA;

EID: 84893486800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0215630     Document Type: Erratum

References (29)

1. Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40: 221-226.
2. Gagneux-Brunon A, Mariat C, Delanaye P (2012) Cystatin C in HIV-infected patients: promising but not yet ready for prime time. Nephrol Dial Transplant 27: 1305-1313.
3. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, et al. (2006) Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis 185: 375-380.
4. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K (2012) Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 156: 785-795, W-270, W-271, W-272, W-273, W-274, W-275, W-276, W-277, W-278.
5. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
6. Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, et al. (2012) Performance of Creatinine and Cystatin C GFR Estimating Equations in an HIV-Positive Population on Antiretrovirals. J Acquir Immune Defic Syndr 61: 302-309.
7. Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, et al. (2013) Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS.
8. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, et al. (1991) The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 109: 75-100.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
10. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, et al. (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52: 5-18.
11. Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, et al. (2010) First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48: 1619-1621.
12. Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, et al. (1994) CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J Infect Dis 170: 775-781.
13. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
14. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A (2006) Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 69: 2070-2077.
15. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29.
16. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
17. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. (2009) Research electronic data capture (REDCap) - A metadata-driven methodology and work-flow process for providing translational research informatics support. J Biomed Inform 42: 377-381.
18. Benito JM, Lopez M, Lozano S, Martinez P, Gonzalez-Lahoz J, et al. (2004) CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 20: 227-233.
19. Beran O, Holub M, Spala J, Kalanin J, Stankova M (2003) Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART. Acta Virol 47: 121-124.
20. Praditpornsilpa K, Avihingsanon A, Chaiwatanarat T, Chaiyahong P, Wongsabut J, et al. (2012) Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS 26: 1781-1788.
21. Barraclough K, Er L, Ng F, Harris M, Montaner J, et al. (2009) A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract 111: c39-48.
22. Estrella MM, Parekh RS, Astor BC, Bolan R, Evans RW, et al. (2011) Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 57: 380-386.
23. Mauss S, Berger F, Kuschak D, Henke J, Hegener P, et al. (2008) Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients. Antivir Ther 13: 1091-1095.
24. Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, et al. (2009) Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 23: 71-82.
25. Jones CY, Jones CA, Wilson IB, Knox TA, Levey AS, et al. (2008) Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. Am J Kidney Dis 51: 914-924.
26. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
27. Choi A, Scherzer R, Bacchetti P, Tien PC, Saag MS, et al. (2010) Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 56: 872-882.
28. Driver TH, Scherzer R, Peralta CA, Tien PC, Estrella MM, et al. (2013) Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS 27: 2291-2299.
29. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, et al. (2011) Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305: 1545-1552.